Skip to content

Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Disease. We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines. Gradually, then all at once...

Demis Hassabis · X· @demishassabis·· 20 hours ago

67.8K views · 3K likes · 281 reposts (at collection)

Original
Article

Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Disease. We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines. Gradually, then all at once...

Reported by 2 sources

    The story so far

    Isomorphic Labs has raised $5 billion in a Series C funding round to advance its drug candidates toward clinical trials. This capital was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and the company's existing investors. The AI drug-discovery platform, which spun out of Google's DeepMind in 2021, stated that it has already achieved positive preclinical results in oncology and immunology. CEO Demis Hassabis described the funding as a step toward the company's mission to use AI to "Solve All Disease," with the goal of radically reducing the time and cost required to discover new medicines. Following this investment, the company plans to continue developing its core drug-design engine and intends to expand its research into further types of medicine.

    Read next

    See the full storyIsomorphic Labs Raises $5 Billion in Series C Funding for AI Drug Development